<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03961178</url>
  </required_header>
  <id_info>
    <org_study_id>CONE</org_study_id>
    <nct_id>NCT03961178</nct_id>
  </id_info>
  <brief_title>A Cohort Study for the Following up of Conization</brief_title>
  <official_title>Oncologic and Obstetric Outcomes After Conization for Uterine Cervical Lesion: A Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lei Li</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to investigate the oncologic and obstetric outcomes in patients with conization
      for uterine cervical lesions from January 1, 2000 to January 1, 2019 in Peking Union Medical
      College Hospital.

      The primary objectives consist of following:

        1. The cumulative incidences of precancerous lesions and cancers of lower genital tract in
           patients who accepted conization for high grade intraepithelial neoplasia (HSIL),
           carcinoma in situ and stage IA1 cancer (FIGO 2009)

        2. The cumulative pregnancy rates in patients sparing the fertility

      The secondary objectives consist of following:

        1. The effects of surgical protocols (modified Sturmdorf method and &quot;8&quot; figure suture) and
           energy equipment (cold knife and monopolar electrical cautery) on the oncologic and
           obstetric outcomes, and on the histological components.

        2. A full description of histological components of the conization specimens

        3. The cytological and virus outcomes after conization, based on the thin prep liquid-based
           cytology test (TCT) and high-risk human papillomavirus (HPV) testing
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 3, 2019</start_date>
  <completion_date type="Anticipated">May 22, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 22, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The cumulative incidences of precancerous lesions or cancers</measure>
    <time_frame>Five years</time_frame>
    <description>The cumulative incidences of precancerous lesions and cancers of lower genital track in patients who accepted conization for high grade intraepithelial neoplasia (HSIL), carcinoma in situ and stage IA1 cancer (FIGO 2009)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The cumulative pregnancy rates</measure>
    <time_frame>Five years</time_frame>
    <description>The cumulative pregnancy rates in patients sparing the fertility</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The cytological results after conization</measure>
    <time_frame>Five years</time_frame>
    <description>The cytological after conization based on the thin prep liquid-based cytology test (TCT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The virus outcomes after conization</measure>
    <time_frame>Five years</time_frame>
    <description>The virus outcomes after conization high-risk human papillomavirus (HPV) testing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The cumulative pregnancy loss rates</measure>
    <time_frame>Five years</time_frame>
    <description>The cumulative pregnancy loss rates in patients sparing the fertility</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The cumulative live birth rates</measure>
    <time_frame>Five years</time_frame>
    <description>The cumulative live birth rates in patients sparing the fertility</description>
  </secondary_outcome>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Precancerous Lesions</condition>
  <condition>Conization</condition>
  <condition>High Grade Intraepithelial Neoplasia</condition>
  <condition>Uterine Cervical Cancer</condition>
  <condition>Fertility</condition>
  <condition>Pregnancy</condition>
  <condition>Human Papillomavirus Infection</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>High-risk HPV</intervention_name>
    <description>High-risk HPV testing for the cytology of lower genital tract</description>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>TCT</intervention_name>
    <description>Thin prep liquid-based cytology test for the cytology of lower genital tract</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population consists of patients accepting conization in the study center who were
        aged 18 years or older.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Accepting conization in the study center

          -  Aged 18 years or older

        Exclusion Criteria:

          -  Not meeting any of the inclusion criteria
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lei Li, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking Union Medical College Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lei Li, M.D.</last_name>
    <phone>+8613911988831</phone>
    <email>lileigh@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ming Wu, M.D.</last_name>
    <phone>+8613911988831</phone>
    <email>wuming@pumch.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Lei Li</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lei Li, MD</last_name>
      <phone>008613911988831</phone>
      <email>lileigh@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>May 22, 2019</study_first_submitted>
  <study_first_submitted_qc>May 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 23, 2019</study_first_posted>
  <last_update_submitted>June 19, 2019</last_update_submitted>
  <last_update_submitted_qc>June 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Peking Union Medical College Hospital</investigator_affiliation>
    <investigator_full_name>Lei Li</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Papillomavirus Infections</mesh_term>
    <mesh_term>Uterine Cervical Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

